CARVANA CO.

CVNA

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 226,963Value: $95.8M

**Signal Note - CVNA Position Initiation** Driehaus Capital's $95.8M entry into Carvana represents a notable shift given the fund's biotech focus and growth mandate—CVNA is an auto e-commerce retailer, not a biotech asset, suggesting either portfolio diversification into adjacent consumer discretionary or a conviction play on operational turnaround post-restructuring. This move is atypical for a biotech-allocative manager and warrants monitoring for potential strategic rationale or fund positioning changes rather than indicating clinical/pipeline developments.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: